Overview

A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder

Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the tolerability and efficacy of different doses of duloxetine in patients with major depressive disorder.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Duloxetine Hydrochloride